ChinaOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 310 out of 156,020 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 8,760 | 9,143 |
| Total Cites | 5,781 | 6,217 |
| H-index | 40 | 41 |
| Hm-index | 15 | 15 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 93 | 103 |
| Number of Single+First+Last Authored Papers | 230 | 230 |
| Total Cites to Single+First+Last Authored Papers | 3,825 | 4,124 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4,107 | 4,243 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.47 |
| Self-Citation Percentage |
7.01%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 205 out of 135,958 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 6,295 | 6,515 |
| Total Cites | 5,203 | 5,595 |
| H-index | 39 | 41 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 132 | 139 |
| Number of Single+First+Last Authored Papers | 216 | 216 |
| Total Cites to Single+First+Last Authored Papers | 3,683 | 3,924 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,484 | 3,626 |
| Ratio of Total Citations to Distinct Citing Papers | 1.49 | 1.54 |
| Self-Citation Percentage |
7.01%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 208 out of 117,692 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 6,953 | 7,446 |
| Total Cites | 4,885 | 5,205 |
| H-index | 39 | 40 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 127 | 133 |
| Number of Single+First+Last Authored Papers | 192 | 192 |
| Total Cites to Single+First+Last Authored Papers | 3,623 | 3,809 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,211 | 3,330 |
| Ratio of Total Citations to Distinct Citing Papers | 1.52 | 1.56 |
| Self-Citation Percentage |
6.15%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 215 out of 103,235 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7,678 | 8,122 |
| Total Cites | 4,636 | 4,972 |
| H-index | 39 | 41 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 164 | 175 |
| Number of Single+First+Last Authored Papers | 177 | 177 |
| Total Cites to Single+First+Last Authored Papers | 3,523 | 3,736 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,882 | 2,990 |
| Ratio of Total Citations to Distinct Citing Papers | 1.61 | 1.66 |
| Self-Citation Percentage |
6.76%
|
|
United StatesOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 251 out of 89,177 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 9,683 | 10,115 |
| Total Cites | 6,452 | 7,007 |
| H-index | 46 | 48 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 274 | 290 |
| Number of Single+First+Last Authored Papers | 158 | 158 |
| Total Cites to Single+First+Last Authored Papers | 5,072 | 5,421 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4,052 | 4,223 |
| Ratio of Total Citations to Distinct Citing Papers | 1.59 | 1.66 |
| Self-Citation Percentage |
7.92%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 2,074 out of 75,210 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 74,467 | 84,804 |
| Total Cites | 984 | 1,033 |
| H-index | 17 | 17 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 148 | 156 |
| Number of Single+First+Last Authored Papers | 35 | 35 |
| Total Cites to Single+First+Last Authored Papers | 718 | 738 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 771 | 788 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.31 |
| Self-Citation Percentage |
4.74%
|
|
Related Profiles
Top 2% Scientists by Country
236,132 scientists from 167 countries on the 2025 single-year list.
United States73,020 scientists, 1st in the world
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.